Vascular cell apoptosis in remodeling, restenosis, and plaque rupture

Circulation Research

Volumn 87, Issue 3, 2000, Pages 184-188

  Walsh, K ^a   Smith, R C ^a   Kim, H S ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Atherosclerosis; Remodeling; Restenosis

Indexed keywords

FAS ANTIGEN; LIGAND; PROTEIN BCL 2; PROTEIN BCL X; RECEPTOR;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELL VIABILITY; ENDOTHELIUM CELL; HEART VENTRICLE REMODELING; INFLAMMATORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR LESION; VASCULAR SMOOTH MUSCLE;

EID: 0033870765     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.3.184     Document Type: Review

References (68)

1. Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus
2. Apoptosis and regulation of Bax and Bcl-X proteins during human neonatal vascular remodeling
3. Apoptosis (programmed cell death) in arteries of the neonatal lamb
4. Effects of changes in blood flow rote on cell death and cell proliferation in carotid arteries of immature rabbits
5. Atrophic remodeling of the artery-cuffed artery
6. Elevated perfusion pressure upregulates endothelin-1 and endothelin B receptor expression in the rabbit carotid artery
7. 3 integrin to promote epidermal growth factor receptor phosphorylation and growth
8. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro. TIMP-3 promotes apoptosis
9. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
10. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1β converting enzyme
11. Apoptosis in human atherosclerosis and restenosis
12. Colocalization of CPP-32 with apoptotic cells in human atherosclerotic plaques
13. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
14. Apoptosis and related proteins in different stages of human atherosclerotic plaques
15. Histopathology of in-stent restenosis in patients with peripheral artery disease
16. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits
17. Atherosclerosis in APOE*3-Leiden transgenic mice: From proliferative to atheromatous stage
18. Apoptotic cell death in atherosclerotic plaques of hyperlipidemic knockout mice
19. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques
20. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis
21. Evidence for the rapid onset of apoptosis in medial smooth muscle cells following balloon injury
22. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty
23. Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand
24. Apoptosis participates in cellularity regulation during rat aortic intimal thickening
25. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
26. Kinetics of cellular proliferation after arterial injury, 1: Smooth muscle cell growth in the absence of endothelium
27. Early cell loss alter angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall
28. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury
29. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease
30. Effect of hypercholesterolemia on the sequential changes of apoptosis and proliferation after balloon injury to rabbit iliac artery
31. Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Role of macrophages
32. Apoptosis and cell proliferation after porcine coronary angioplasty
33. Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces smooth muscle cell apoptosis
34. Co-expression of p53 and MDM2 in human atherosclerosis implications for the regulation of cellularity of atherosclerotic lesions
35. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
36. Identification of a p53-dependent negative response element in the bcl-2 gene
37. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
38. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo
39. WAF1, a potential mediator of p53 tumor suppression
40. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo
41. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand
42. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
43. The Fas death factor
44. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
45. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation
46. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
47. Fas ligand-induced apoptosis as a mechanism of immune privilege
48. A role of CD95 ligand in preventing graft rejection
49. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation
50. Vascular endothelial cells and smooth muscle cells differ in their expression of Fas and Fas ligand and in their sensitivity to Fas ligand-induced cell death: Implications for vascular disease and therapy
51. Oxidized LDL activates Fas-mediated endothelial cell apoptosis
52. Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis
53. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions
54. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
55. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation
56. Human transplant coronary artery disease: Pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy
57. Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirus-mediated T cell response
58. Downregulation of Fas ligand by shedding
59. Activated T cells induce up-regulation of Fas antigen in cultured endothelial cells
60. Fas ligation triggers apoptosis in macrophages but not endothelial cells
61. Inhibition of death receptor signals by cellular FLIP
62. MRIT, a novel death-effector domain-containing protein, interacts with caspases and Bcl(XL) and initiates cell death
63. Endothelial cell apoptosis induced by oxidized LDL is associated with the downregulation of the cellular caspase inhibitor FLIP
64. Expression of cellular FLICE-inhibitor protein in human coronary arteries and in a rat vascular injury model
65. Sequential study of vasculitis in MRL mice
66. Role of macrophages in the development of arteritis in MRL strains of mice with a deficit in Fas-mediated apoptosis
67. Fas ligand-deficient mice display enhanced leukocyte infiltration and intima hyperplasia in flow-restricted vessels
68. Adenovirus-mediated delivery of Fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals